ABSTRACT
Picornaviridae family comprises single-stranded, positive-sense RNA viruses distributed into forty-seven genera. Picornaviruses have a broad host range and geographic distribution in all continents. In this study, we applied a high-throughput sequencing approach to examine the presence of picornaviruses in penguins from King George Island, Antarctica. We discovered and characterized a novel picornavirus from cloacal swab samples of gentoo penguins (Pygoscelis papua), which we tentatively named Pingu virus. Also, using RT-PCR we detected this virus in 12.9 per cent of cloacal swabs derived from P. papua, but not in samples from adélie penguins (Pygoscelis adeliae) or chinstrap penguins (Pygoscelis antarcticus). Attempts to isolate the virus in a chicken cell line and in embryonated chicken eggs were unsuccessful. Our results expand the viral diversity, host range, and geographical distribution of the Picornaviridae.
ABSTRACT
The thermostability (TS) and efficacy offered by live vaccines against Newcastle disease strains B1, La Sota, VG-GA and Ulster, produced or imported by four Brazilian laboratories, were evaluated during their validity period. Kinetic profiles were obtained from samples conserved in refrigerators during 0, 4, 8, 12, 16, 20 and 24 months after their manufacturing. The statistical analysis of the vaccine titre effect obtained by the fresh air (FA) method showed that the vaccine profiles were parallel and coincident, presenting a significant descending trend. The vaccine titres and efficiency proofs at the end of the validity period were above the level of legislation requirements and showed an average loss in titre of 0.40 and 0.66 log(10,) within the first and second validity years, respectively. The titre obtained by TS, within the month after manufacturing, had no significant difference from the titre obtained by FA within 24 months after manufacturing, being their pairs of observations positively correlated (r=0.49, p=0.0003), showing that the TS method, which anticipates the vaccines' performance at the end of the validity period, can substitute the FA method 24 months after manufacturing.
Subject(s)
Newcastle Disease/prevention & control , Viral Vaccines/therapeutic use , Animals , Brazil , Chickens/blood , Chickens/immunology , Cold Temperature , Commerce , Drug Stability , Newcastle Disease/immunology , Newcastle Disease/mortality , Specimen Handling/adverse effects , Time Factors , Titrimetry , Treatment Outcome , Viral Vaccines/chemistryABSTRACT
O vírus da doença de Newcastle (VDN) é o agente etiológico de uma das doenças mais importantes da avicultura e tem sido identificado na maioria das espécies aviárias, silvestres e domésticas. Neste trabalho, obteve-se o isolamento em ovos embrionados da amostra denominada JAP99 do VDN, a partir de fezes de patos coletadas no Município de Japeri, RJ. A amostra foi identificada pela técnica da inibição da hemaglutinação (HI) e a caracterização biológica da patogenicidade do novo isolado foi realizada no Laboratório Regional Animal, MAPA, Campinas, SP (LARA-Campinas). Pela inoculação intracerebral em pintos de um dia (IPIC), o índice foi 1,4. Na inoculação intravenosa em aves de seis semanas (IPIV), o índice encontrado foi 0,0 (zero) e o tempo médio de morte embrionária (TMME) foi de 62 horas. Estes resultados indicaram que o isolado JAP99 é mesogênico para galinhas comerciais, oferecendo risco para a avicultura industrial.
